Skip to main content
Premium Trial:

Request an Annual Quote

Skyline Dx, Janssen Partner on Companion Dx Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Dutch array-based diagnostics firm Skyline Diagnostics today announced a deal with Janssen Pharmaceutica for the analysis of an undisclosed marketed compound.

Under the terms of the deal, Skyline will use its expertise and technologies in genetic profiling and bioinformatics to generate and analyze diagnostics information related to the compound from Janssen.

Skyline will receive R&D funding and is eligible for certain research milestone payments. Further terms of the deal were not disclosed.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.